Top Story

Radioactive iodine improved survival in differentiated thyroid carcinoma

October 30, 2014

CORONADO, Calif. — Use of radioactive iodine therapy was linked to improved disease-specific survival in patients with advanced differentiated thyroid carcinoma, according to study results presented at the American Thyroid Association annual meeting.

However, researchers noted that radioactive iodine (RAI) demonstrated negative effects among patients with micropapillary carcinoma.

In the Journals

Efficacy of VTE chemoprophylaxis in otolaryngology patients varied by subgroup

October 24, 2014
The efficacy and safety of venous thromboembolism chemoprophylaxis for individuals undergoing otolaryngologic surgery varied based on Caprini risk score and the type of…
FDA News

FDA grants priority review to lenvatinib for advanced thyroid cancer

October 15, 2014
The FDA granted priority review status to lenvatinib mesylate as a treatment for patients with progressive radioactive iodine-refractory differentiated thyroid cancer…
In the Journals

E-cigarettes unhelpful for smoking cessation among patients with cancer

October 13, 2014
A study of patients with cancer who smoke showed those who used electronic cigarettes were more nicotine-dependent than nonusers.Those who used e-cigarettes also were…
CME
figure

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »

Filter By:

Meeting News Coverage

Radioactive iodine improved survival in differentiated thyroid carcinoma

October 30, 2014
CORONADO, Calif. — Use of radioactive iodine therapy was linked to improved disease-specific survival in patients with advanced differentiated…
In the Journals

Efficacy of VTE chemoprophylaxis in otolaryngology patients varied by subgroup

October 24, 2014
The efficacy and safety of venous thromboembolism chemoprophylaxis for individuals undergoing otolaryngologic surgery varied based on Caprini risk…
FDA News

FDA grants priority review to lenvatinib for advanced thyroid cancer

October 15, 2014
The FDA granted priority review status to lenvatinib mesylate as a treatment for patients with progressive radioactive iodine-refractory…
In the Journals

E-cigarettes unhelpful for smoking cessation among patients with cancer

October 13, 2014
A study of patients with cancer who smoke showed those who used electronic cigarettes were more nicotine-dependent than nonusers.Those who used…
figure In the Journals

Preoperative ultrasound imaging of thyroid cancer essential to preventing additional surgeries

October 8, 2014
The use of comprehensive preoperative imaging enables complete initial surgical removal of thyroid cancer and associated metastases from cervical…
figure In the Journals

Current tobacco use linked to oral HPV-16 infection

October 7, 2014
Tobacco users demonstrated twice the risk for oral HPV-16 infection than former tobacco users or never users, according to study results.HPV-16, a…
figure In the Journals

One-third of cancer patients experienced anxiety, mental health disorders

October 6, 2014
About one in three patients with cancer experienced some level of clinically relevant mental health challenge, such as anxiety, depressive disorders…
Meeting News Coverage

Cancer incidence in type 1 diabetes similar to general population

September 23, 2014
Site-specific cancer patterns in type 1 diabetes largely follow incidence in patients with type 2 diabetes, but more minimal, and do not drastically…
FDA News

FDA grants orphan drug status to Lymphoseek for head and neck cancers

September 19, 2014
The FDA granted orphan drug designation to the radioactive diagnostic imaging agent technetium 99m tilmanocept for sentinel lymph node detection in…
figure In the Journals

Cetuximab plus radiation, cisplatin yielded little benefit in advanced head and neck cancers

September 12, 2014
The addition of cetuximab to cisplatin-based radiation therapy conferred no significant benefit with regard to PFS, OS, locoregional failure or…
More Headlines »